BURLINGTON, Mass., May 31, 2018 /PRNewswire-PRWeb/ -- Azara Healthcare, a leading provider of data-driven reporting and
NCQA PCMH Prevalidation is a voluntary review process that includes a rigorous evaluation of DRVS functionality to support the Patient Centered Medical Home as a model of care capable of transforming the delivery of primary care. The model is based on the philosophy that primary care should be patient-centered, comprehensive team-based, coordinated, accessible and focused on quality and safety. Using DRVS allows for the visualization and use of clinical and payer data to achieve these goals necessary for the transition to value-based care and the transformation of primary care.
"We are pleased to offer NCQA Prevalidation to the community health centers that use DRVS and the PCMH model of care," said Jeff Brandes, Azara President and CEO. "With the demands of healthcare reform, we will continue to provide centers with the tools they need to advance their practice."
NCQA's PCMH Prevalidation evaluates Electronic Health Record (EHR) systems, advanced registries, population health management tools, care coordination tools, patient engagement tools and other related health technology solutions providing functionality that completely meet or support requirements within applicable NCQA PCMH Standards. If a Health IT solution completely meets the functional requirements of a given factor, automatic credit, "autocredit" points are awarded. If the health IT solution provides significant functionality that aligns with the requirements of the PCMH standards for a given factor, but does not fully meet the factor level requirement, a "supporting" designation is awarded. Once a solution receives autocredit or a supporting designation for one or more factors, it is considered "Prevalidated." Practices that use an NCQA Prevalidated system with autocredit awarded to a factor do not have to submit documentation for that associated factor within their PCMH Survey.
PCMH Prevalidation is designed to help practices identify health IT solutions that alleviate or make more efficient administrative aspects of meeting NCQA PCMH Program requirements.
"By providing software that helps physician practices build the patient-focused, coordinated care infrastructure expected of NCQA patient-centered medical homes, Azara is helping practices be part of modern health care's most important transformations," said NCQA President Margaret E. O'Kane. "Medical homes are the way of the future, and Azara is helping practices get there."
Azara Healthcare's DRVS is prevalidated by NCQA to receive 10 Fully Meets Eligible Transfer Credits and 8 Partially Meets Eligible Transfer Credits toward NCQA's PCMH 2017 scoring. DRVS also received a supporting designation (Practice Support) for 24 criteria in the PCMH 2017 standards. Autocredit is transferrable to Azara's PCMH client practices seeking NCQA's PCMH Recognition. Azara's PCMH eligible client practices must be actively utilizing the reviewed capabilities associated with Azara's PCMH prevalidated product in order to be eligible for transfer of awarded autocredit.
Resources are available for DRVS users to guide them through the NCQA Prevalidated process.
About NCQA NCQA is a private, non-profit organization dedicated to improving health care quality. NCQA accredits and certifies a wide range of health care organizations. It also recognizes clinicians and practices in key areas of performance. NCQA's Web site (http://www.ncqa.org) contains information to help consumers, employers and others make more informed health care choices.
About Azara Healthcare Azara Healthcare is a leading provider of data-driven reporting and analytics for the Community Health marketplace. Azara solutions empower Community Health Centers, Primary Care Associations and Health Center Controlled Networks to improve the quality and efficiency of care delivery through actionable data. The Azara Data Reporting and Visualization System (DRVS) helps the marketplace meet the demands of healthcare reform and achieve the goals of the Quadruple Aim. DRVS is used at more than 250 health centers in 25 states representing over 19 million lives.
SOURCE Azara Healthcare
Subscribe to our Free Newsletters!
Alström syndrome, a rare genetic disorder due to ALMS1 mutations, occurs in the first year of ...
Sodium zirconium cyclosilicate was approved by FDA recently to use as an oral suspension for ...
Encephalocele is a birth defect where a sac like protrusion of brain and covering membranes occurs ...View All